BioVentrix Competitors and Similar CompaniesClear all

BioVentrix's competitors and similar companies include Evergen, Emulate, Seegene and Cardiac Dimensions.

	BioVentrix BioVentrix is a medical device company with a mission to improve and expand the treatment available for congestive heart failure caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.	Evergen Evergen (formerly known as RTI Surgical) is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.	Emulate Emulate is a biotechnology company that specializes in organ-on-chips technology.	Seegene Seegene ((주)씨젠) is a company that manufactures molecular diagnostics products.	Cardiac Dimensions Cardiac Dimensions is a medical device company developing tools and techniques for the treatment of heart failure and related conditions.
Founding Date	Founding Date 2003	Founding Date 1998	Founding Date 2014	Founding Date 2000	Founding Date 2000
Type	Type Private	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices
Locations	Locations San Ramon, US HQ Hilden, DE	Locations Alachua, US HQ Metz, FR Neunkirchen Am Brand, DE Houten, NL Singapore, SG Greenville, US Marquette, US see more	Locations Boston, US HQ	Locations Seoul, KR HQ Contagem, BR Toronto, CA Düsseldorf, DE Genova, IT Ciudad De México, MX Dubai, AE see more	Locations Kirkland, US HQ Macquarie Park, AU Offenbach Am Main, DE
Employees	Employees N/A	Employees 8915% decrease	Employees 802% decrease	Employees 88478% increase	Employees 653% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $280.9m (FY, 2018)	Revenue (est.) N/A	Revenue (est.) ₩474.2b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $140.7m (FY, 2018)	Cost of goods N/A	Cost of goods ₩133.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $140.1m (FY, 2018)	Gross profit N/A	Gross profit ₩345b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($1.3m) (FY, 2018)	Net income N/A	Net income ₩48.4b (FY, 2025)	Net income N/A
Operating ⚠
Countries	Countries N/A	Countries 45 (FY, 2016)	Countries N/A	Countries 48 (Q2, 2020)	Countries N/A
Funding
Latest funding round	Latest funding round $ 14.5m (almost 9 years ago)	Latest funding round N/A	Latest funding round $ 36m (almost 8 years ago)	Latest funding round N/A	Latest funding round $ 17.5m (over 5 years ago)
Total funding raised	Total funding raised $ 28.9m	Total funding raised N/A	Total funding raised $ 95m	Total funding raised N/A	Total funding raised $ 178.5m